IDEAYA Bioscience’s rare cancer drug shows benefit in interim Phase II data, with the company announcing the drugs Phase III ...

The US FDA previously granted fast track designation for fasedienol for the acute treatment of social anxiety disorder. Credit: mojo cp / Shutterstock. US-based biopharmaceutical company Vistagen has ...

The new safety data from Phase III and I trials showing an absence of postinjection syndrome, a rare and serious side effect ...

Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Novo Nordisk will be initiating a Phase IIb trial of monlunabant to answer some questions about the drug before initiating a pivotal study. Image credit: Shutterstock / Kittyfly. Questions remain over ...

The patients in the trial had previously undergone endocrine-based therapy and at least one other systemic therapy. Credit: Maria Sbytova / Shutterstock. AstraZeneca and Daiichi Sankyo have reported ...

Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...

The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...

In Part A of the CIRRUS-HCM trial, patients with obstructive HCM received a single dose of 50, 100, or 200mg of EDG-7500. Credit: Inside Creative House/Shutterstock. Edgewise Therapeutics has ...

The lead asset is being developed for treating Group 2 pulmonary hypertension-heart failure with preserved ejection fraction. Credit: sasirin pamai / Shutterstock. Tectonic Therapeutic has reported ...